Source: International Congress 2014 – Animal models in respiratory drug development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. CorrêaFlorencio, F. M. Arantes-Costa, R. Santos de Almeida, S. S. S. Hamaguchi, S. D. Sasaki, M. A. Martins, I. F. L. C. Tibério, F. D. T. Q. S Lopes, E. A. Leick (São Paulo, Santo André, Brazil). BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice. Eur Respir J 2014; 44: Suppl. 58, 1784

Member's Comments

No comment yet.

Related content which might interest you: BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Effects of phosphoinositide-3-kinase inhibitors on steroid-insensitive airway inflammation in poly(I:C) and allergen challenged mice Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Treatment with Syk inhibitors after establishment of disease phenotype in a chronic HDM model of allergic airways inflammation abolishes AHR and attenuates inflammatory mediator expression Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD Year: 2015 Acid sphingomyelinase deficiency improves lung function in allergen-induced asthma in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The effect of lipopolysaccharide-contaminated ovalbumin on airway inflammation and remodeling in a chronic murine asthma model Source: Annual Congress 2013 –Murine models of lung immunology Year: 2013 PI3Kδ inhibition confer efficacy in experimental models of allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 LATE-BREAKING ABSTRACT: Inhibition of TRPA1 reduces airway inflammation and airway hyper-responsiveness in a murine model of allergic rhinitis Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease Year: 2016 Vitamin C inhibits the diisocyanate-induced lung inflammatory response in mice Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease Year: 2015 Characteristics of IL-25 and allergen-induced airways fibrosis in a murine model of asthma Source: International Congress 2015 – The immunology of allergic airway disease Year: 2015 Immunohistochemical study on changes of mast cell populations during allergic airway inflammation in mice using HDM model Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions Year: 2015 Characterisation of a steroid-insensitive severe asthma model Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 IL-13 in a mouse model of chemical-induced airway hyperresponsiveness Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 The effect of trehalose for the allergen-induced airway hyperresponsiveness and airway inflamation in mice Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation Year: 2013 The immunomodulatory activity of protein S protects against allergic airway inflammation Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Effects of acute hypochlorite exposure in OVA-sensitized and challenged mice Source: International Congress 2015 – Occupational and environmental effects: in vitro and animal models Year: 2015 Influenza induced exacerbation is associated with steroid insensitive AHR and pulmonary inflammation in HDM-sensitised mice Source: International Congress 2016 – Immune responses in the lung Year: 2016 Over-expression of the LTC4 synthase gene in mice reproduces human aspirin-induced asthma (AIA) Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy Year: 2013 New inhaled JAK inhibitor LAS194046 inhibits allergen-induced airway inflammation in Brown Norway rats Source: International Congress 2014 – New drugs for asthma, COPD and pulmonary fibrosis Year: 2014 Species comparison of interleukin-13 induced airway hyperreactivity as model for allergic asthma Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014 Lack of involvement of type 7 phosphodiesterase in an experimental model of asthma Source: Eur Respir J 2012; 39: 582-588 Year: 2012